Why the study?
Tricuspid regurgitation has a complex pathophysiology with limited medical and surgical options, prompting investigation into transcatheter devices with potentially lower morbidity and mortality.
Design
Review
Authors
Loading...
Transcatheter TR devices remain investigational; leaves open the need for randomized efficacy and safety data.
Transcatheter devices represent an emerging therapeutic approach for tricuspid regurgitation, offering potential alternatives to high-risk open surgical procedures.
Blusztein et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: